Download by
Scanning QR Code
No Stock Yet
No Data
Changes in Hong Kong stocks | Anti-epidemic concept stocks rose collectively. The first domestic COVID-19 oral medicine can be temporarily included in health insurance reimbursement.
On August 15, Gelonghui concept stocks rose collectively, Development Pharmaceutical B rose nearly 4%, Dongyang Guangyao rose 3%, CSPC Pharmaceutical and JD Health rose 2%, Alibaba Health Information Technology and Sihuan Pharmaceutical rose more than 1.5%, Tengsheng Boyao and Sino Biopharmaceutical followed. According to National Healthcare Security Administration, in accordance with the relevant provisions of basic medical insurance, in order to better protect the needs of diagnosis and treatment, all drugs included in COVID-19 's diagnosis and treatment plan can be temporarily included in the scope of medical insurance payment. On August 9, the National Health Commission issued a notice to include Azvudine tablets in COVID-19 's diagnosis and treatment plan, so the medical insurance fund can be used by insured patients when they use the drug.
Most science and Internet stocks rose, with Trip.com and Bilibili Inc. up more than 3% and Alibaba Health Information Technology and JD Health up more than 2%.
JD Health (06618.HK) held a board meeting on August 23rd to approve interim results and its release.
JD Health (06618.HK) announced that the company will hold a board meeting on Tuesday, August 23, 2022 to, among other things, approve the unaudited interim results of the company and its subsidiaries for the six months ended June 30, 2022 and their announcements, and consider recommending the payment of an interim dividend (if any). Management will hold a conference call at 09:30 (Beijing ╱ Hong Kong time) on Wednesday, August 24, 2022 to discuss the interim results of the Company and its subsidiaries for the six months ended June 30, 2022.
JD Health: date of board meeting
Four departments: strengthen the monitoring of the shortage of drugs and the production and reserve of selected drugs in the centralized procurement of drugs organized by the state
New inactivated crown vaccine approved for children aged 6 months and above for the first time
Quick look in intraday trading | the three major indexes rose collectively, and the trends of science and technology stocks and semiconductor stocks were strong.
Science and technology stocks collectively strengthened, Bilibili Inc. rose more than 6%, BABA and JD.com rose more than 5%; Apple Inc concept stocks rose, Gao Wei Electronics rose more than 12%, BYD Electronic rose 9%; pharmaceutical outsourcing concept stocks strengthened, Kailiying rose more than 9%. Wuxi Apptec and Wuxi Biologics rose more than 4%.
Pride and Prejudice of innovative drugs: talking about "License-in" in controversy
Hong Kong stock Hang Seng Technology Index fell 5% BABA fell nearly 7%
The Hang Seng Technology Index of Hong Kong stocks fell 3%, JD Health, Alibaba Health Information Technology and Kuaishou Technology fell more than 6%, Bilibili Inc. and BYD Electronic fell more than 5%, BABA fell more than 5%, the market capitalization f
Loading...
No Stock Yet